Logo image of HI.MI

HEALTH ITALIA SPA (HI.MI) Stock Analyst Earnings Estimates

BIT:HI - Euronext Milan - IT0005585861 - Common Stock - Currency: EUR

283  +3 (+1.07%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
HI.MI revenue by date.HI.MI revenue by date.
39.222M
-0.89%
35.67M
-9.06%
35.363M
-0.86%
EBITDA
YoY % growth
HI.MI ebitda by date.HI.MI ebitda by date.
8.345M
53.04%
6.771M
-18.86%
5.651M
-16.54%
EBIT
YoY % growth
HI.MI ebit by date.HI.MI ebit by date.
6.805M
68.63%
5.517M
-18.93%
4.543M
-17.66%
Operating Margin
HI.MI operating margin by date.HI.MI operating margin by date.
17.35%15.47%12.85%
EPS
YoY % growth
HI.MI eps by date.HI.MI eps by date.
N/AN/AN/A
31.25%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
HI.MI Yearly EPS VS EstimatesHI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 5 10 15 20
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
16.055M
-10.10%
%
Q2 2024
Q2Q % growth
19.308M
8.41%
%
Q4 2023
Q2Q % growth
17.86M
-10.58%
%
Q2 2023
Q2Q % growth
17.81M
-7.47%
%
Q4 2022
Q2Q % growth
19.973M
-5.25%
%
Q2 2022
Q2Q % growth
19.249M
4.07%
%
Q4 2021
Q2Q % growth
21.079M
16.35%
%
Q2 2021
Q2Q % growth
18.497M
31.13%
%
Q4 2020
Q2Q % growth
18.117M
7.17%
%
Q2 2020
Q2Q % growth
14.105M
-3.10%
%
HI.MI Yearly Revenue VS EstimatesHI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A